Liver Cancer Center
- News
- Slideshows
- Features
- FDA Alerts
- Releases
- All
First Liver Cancer Rx in Almost 10 Years
The US Food and Drug Administration (FDA) has approved the first medication to treat liver cancer in nearly 10 years.
How Ethnicity Affects Cancer Risk
Your ethnicity may be a factor in your cancer risk.
Smoking Might Be Even More Dangerous Than You Think
There are countless reasons to quit smoking. And new data may add 12 more reasons to the list.
Statins Could Help More Than Your Heart
High cholesterol and liver cancer may have a common enemy.
Cancer Survival Gains Not the Same for All Groups
Cancer patients are winning the battle against the disease like never before, but age and race may play a role in determining survival odds.
This Hep C Rx Combo May Be Quicker Cure
For people with hepatitis C, three isn't a crowd. These patients got well much faster with the addition of a third medication.
Cirrhosis: Usually Preventable but Common
Cirrhosis of the liver may usually be preventable, but it may be more common than previously thought. Fortunately, patients can take simple steps to keep their livers in tip-top shape.
Cancer Screening May Benefit Diabetes Patients
Diabetes patients may need to take extra precautions to lower their risk for cancer or catch it early.
High Blood Glucose Levels Associated With Cancer
Having too much sugar in your blood, even if you are not diabetic, is considered unhealthy. And there may be an association between having high blood sugar levels and developing a serious health condition.
Liver Cancer Rx Failed Further Testing
Even when new medications show a lot of promise in the early stages of testing, they don't always prove to work so well in later stages of testing. For certain liver cancer patients, everolimus (Afinitor) may be less effective against tumors than previously thought.
A Way to Spot Liver Cancer Sooner in Cirrhosis Patients
People with scarring of their liver (known as cirrhosis) are at risk for liver cancer. New research suggests there may be a way to detect this cancer earlier, thus improving survival odds.
Fifty Years Later, Work Remains to Curb Smoking
Fifty years ago, the US Surgeon General first warned of the dangerous effects of smoking. On the anniversary of that announcement, the current Surgeon General has released new data.
Why Liver Cancer Rates Are Soaring in Minorities
New cases of liver cancer have tripled in the last three decades. The largest increases in incidence are being seen in Latinos. Why is that?
Liver Cancer Isn’t a Coffee Drinker
One of the world's most popular beverages — coffee — may be more than a great way to jump start the day. Mounting evidence suggests coffee beans are full of healthy compounds that may help ward off a number of diseases, including cancer.
Does NSAID Use Impact GI Cancers?
Aspirin is an intriguing medicine because it helps to control inflammation, which plays a big role in a number of diseases — including cancer. So does aspirin help prevent and treat certain types of cancer?
Let Your Liver Enjoy More Coffee
Scientists haven’t pinpointed the exact reason why coffee may be able to protect the liver from cancer. But they have found a good bit of evidence to support coffee’s role in reducing the risk of liver cancer.
Statins May Reduce Liver Cancer Risks
Statins have been around for years to help lower cholesterol. Research has suggested that these medicines may help prevent cancer. A new study supports the mounting evidence.
Cancer Gone in 60 Seconds
Now this is amazing! An international team of researchers has found a way to watch in real time the assassination of cancer. In about a minute, they could literally see liver tumors shrink. How cool is that?
Liver Cancer Going Viral
It’s hard to treat something you don’t understand. A recent study has expanded our understanding of how liver cancer starts. This information might lead to new drugs to treat this bad actor.
Liver Defense with Aspirin
Drugs like aspirin have been shown to reduce inflammation and the risk of many cancers. However, it has been unclear whether these drugs lower the risk of serious liver problems.